BALAXI PHARMACEUTICALS LIMITED (BALAXI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a cash flow conversion efficiency ratio of 0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs149.66 Million ≈ $1.62 Million USD) by net assets (Rs2.38 Billion ≈ $25.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BALAXI net asset quality score to measure how much of total assets are equity-financed.
BALAXI PHARMACEUTICALS LIMITED - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is BALAXI PHARMACEUTICALS LIMITED's earnings quality to evaluate the quality of earnings relative to operating cash generation.
BALAXI PHARMACEUTICALS LIMITED Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gold Springs Resource Corp
TO:GRC
|
-0.005x |
|
FN Factory Outlet Public Company Limited
BK:FN
|
-0.020x |
|
IRIDEX Corporation
NASDAQ:IRIX
|
0.120x |
|
Vichitbhan Palmoil Public Company Limited
BK:VPO
|
-0.267x |
|
TPC Co. Ltd
KQ:130740
|
0.007x |
|
Observe Medical Asa
OL:OBSRV
|
-0.829x |
|
Hotel Shilla Co Ltd
KO:008775
|
-0.137x |
|
Sampann Utpadan India Limited
NSE:SAMPANN
|
-0.203x |
Annual Cash Flow Conversion Efficiency for BALAXI PHARMACEUTICALS LIMITED (2013–2025)
The table below shows the annual cash flow conversion efficiency of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see BALAXI company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.32 Billion ≈ $25.06 Million |
Rs-377.82 Million ≈ $-4.09 Million |
-0.163x | -774.66% |
| 2024-03-31 | Rs2.01 Billion ≈ $21.78 Million |
Rs48.66 Million ≈ $526.25K |
0.024x | -27.26% |
| 2023-03-31 | Rs1.83 Billion ≈ $19.78 Million |
Rs60.75 Million ≈ $657.02K |
0.033x | -88.99% |
| 2022-03-31 | Rs1.13 Billion ≈ $12.24 Million |
Rs341.44 Million ≈ $3.69 Million |
0.302x | +632353.73% |
| 2021-03-31 | Rs649.80 Million ≈ $7.03 Million |
Rs31.00K ≈ $335.25 |
0.000x | +100.01% |
| 2020-03-31 | Rs277.46 Million ≈ $3.00 Million |
Rs-140.62 Million ≈ $-1.52 Million |
-0.507x | -18.39% |
| 2019-03-31 | Rs35.21 Million ≈ $380.73K |
Rs-15.07 Million ≈ $-162.98K |
-0.428x | +1.89% |
| 2018-03-31 | Rs15.55 Million ≈ $168.13K |
Rs-6.78 Million ≈ $-73.35K |
-0.436x | -3.84% |
| 2017-03-31 | Rs23.59 Million ≈ $255.13K |
Rs-9.91 Million ≈ $-107.20K |
-0.420x | +88.57% |
| 2016-03-31 | Rs314.87K ≈ $3.41K |
Rs-1.16 Million ≈ $-12.52K |
-3.676x | -156.12% |
| 2015-03-31 | Rs322.45K ≈ $3.49K |
Rs2.11 Million ≈ $22.84K |
6.551x | +2233.63% |
| 2014-03-31 | Rs7.80 Million ≈ $84.33K |
Rs-2.39 Million ≈ $-25.89K |
-0.307x | -171.16% |
| 2013-03-31 | Rs7.52 Million ≈ $81.34K |
Rs3.25 Million ≈ $35.09K |
0.431x | -- |
About BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ve… Read more